Mesothelioma Web logo

 

Clinical Trials at University of Chicago Comprehensive Cancer Center


Multicenter Randomized Comparative Phase III Trial of Onconase vs. Doxorubicin in Patients with Malignant Mesothelioma

Phase II Study of Capecitabine in Patients With Malignant Mesothelioma

Phase II Study of SU5416 in Patients With Unresectable Malignant Mesothelioma

Back to Comprehensive Cancer Centers